Enjoy complimentary customisation on priority with our Enterprise License!
The global immunohematology market size is estimated to grow by USD 1.07 billion, at a CAGR of 7.35% between 2023 and 2028. The market dynamics are evolving, spurred by the end-users' transition towards automated immunohematology analyzers. This shift is propelled by the growing demand for blood banks and their capacity to drive sales upwards. Furthermore, sales are expected to surge through service-oriented sales organizations and Group Purchasing Organizations (GPOs), highlighting a rising trend toward collaborative and streamlined procurement processes. This convergence of factors underscores a significant transformation within the immunohematology analyzer market, with automation, demand from blood banks, and strategic sales approaches reshaping its landscape and potential for growth. It also includes an in-depth analysis of drivers, trends, and challenges. Our market growth and forecasting report examines historic data from 2018 - 2022 , besides analyzing the current market scenario.
To learn more about this report, Request Free Sample
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Becton Dickinson and Co: The company offers several immunohematology products, such as BD Vacutainer serum tubes and BD Vacutainer EDTA tubes among others.
Biomed Global, Bio Rad Laboratories Inc., biosurfit SA, Cardinal Health Inc., Calibre Scientific Inc., Danaher Corp., DIAGAST SAS, Grifols SA, Hemo bioscience Inc., HUMAN Gesellschaft fur Biochemica und Diagnostica mbH, Institut de Biotechnologies Jacques Boy, MAK SYSTEM S.A., Merck KGaA, Mesa Laboratories Inc., Quotient Ltd., Siemens AG, Thermo Fisher Scientific Inc., Tulip Diagnostics Pvt. Ltd., and Werfenlife SA
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The analyzers and systems segment is estimated to witness significant growth during the forecast period. Factors such as the high demand potential of automated analyzers in blood banks and next-generation immunohematology analyzers with better throughput will significantly influence the growth of the immunohematology analyzer and system market. Several market players in the market are focusing on developing next-generation immunohematology analyzers with improved speed, performance, and automation.
Get a glance at the market contribution of various segments Download PDF Sample
The analyzers and systems segment was the largest segment and was valued at USD 1.27 billion in 201. For instance, Immucor developed NEO that targets Tier 1 hospitals and reference laboratories. The main advantage of this analyzer is that it can process 224 test samples at the same time and offer a broad test menu for the recipient and donor. There is a growing prominence for automated immunohematology analyzers due to their high potential for manual blood bank testing replacement. As a result, the analyzer is being considered an ideal option as well as a possible replacement for traditionally performed manual methods in blood bank testing. Hence, such factors are expected to fuel the growth of this segment which in turn will drive the market growth during the forecast period.
For more insights about the market share of various regions Download PDF Sample
North America is estimated to contribute 36% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers will shape the market during the forecast period. One of the main reasons for the market in North America is factors such as the rising number of hospital-acquired infections (HAIs) in individuals. Additionally, there is an increasing need for blood in surgical procedures including general surgery or organ transplantation. One of the main dominant markets in North America in the market is the US. As per the CDC, in the US, 3.2% of patients suffer from at least one hospital-acquired infection (HAI) in a day. Some of the conditions in HAIs include pneumonia, bloodstream-related infections, and other types of infections. There are several government initiatives to spread awareness of the Affordable Care Act (ACT) for medical safety has significantly contributed to the market growth. Hence, such factors are expected to drive the market in the region during the forecast period.
Immunohematology plays a pivotal role in addressing trauma cases and elective surgical procedures by providing crucial blood transfusion services. From blood disorders like hemophilia to conditions such as sickle cell disease, immunohematology addresses diverse medical needs through the study of antibodies and red blood cells. Research published in journals like PLOS One and initiatives by organizations like the Leukemia Foundation contribute to advancements in the field, combating challenges like hemolysis and ensuring safe blood transfusion practices. With a focus on immunohematology tests, the market addresses immunity-related reactions and transplant-related reactions, including those related to pregnancy and HIV. Awareness campaigns highlight the importance of blood products and immunohematology technologies in managing blood-associated diseases, expanding the market space for healthcare services and blood component services. In the wake of coronavirus, the immunohematology market continues to evolve, driving innovation and improving patient outcomes through cutting-edge research and technology. Our researchers analyzed the market research and growth data with 2023 as the base year, along with the key market growth analysis, trends, and challenges. A holistic analysis of drivers, trends, and challenges will help companies refine their marketing strategies to gain a competitive advantage.
One of the key factors driving the market growth is the growing demand for blood banks and their potential to increase sales. There is an increasing demand for blood banks across the world. These blood banks collect and store blood from donors by utilizing a bloodmobile or the donors can visit the centers for blood donation. It is then transfused to many screening tests, including screening for infectious disease and blood typing, and serological tests for blood plasma.
Moreover, one of the important aspects in the market is cord blood banking. Once the cord blood is donated, the blood bank preserves it after subjecting it to several tests, including immunohematology. Hence, the growing demand for blood components and cord blood for storage in the blood bank and transfusion is expected to drive the market during the forecast period.
A key factor shaping the market growth is the paradigm shift toward molecular immunohematology. One of the main methods that help in the identification of the molecular and genetic basis of any antigen is molecular analysis. The main advantage of this method is that it helps clinicians understand the molecular basis of blood group antigens and blood typing.
Additionally, there is a growing popularity for blood grouping reagents as it is the ideal method to understand the cross-matching of donor and recipient blood. Furthermore, there is an increasing adoption of molecular immunohematology along with serological typing and HLA typing across many blood banks and hospitals. Hence, such factors, coupled with the demand for Blood grouping reagents, are expected to drive the market during the forecast period. These reagents play a crucial role in ensuring accurate blood transfusions by determining blood types and identifying compatibility between donors and recipients, thereby enhancing the efficiency and safety of transfusion practices in healthcare settings.
High maintenance costs and low reimbursement for blood components are some of the key challenges hindering market growth. There is an increasing cost burden on blood banks due to the increasing cost of the maintenance of blood components associated with labor cost, reagents and disposables cost, and storage. For instance, the average cost of cord blood handling is around USD 1,500 per year.
As a result, several public and private blood banks enforce a charge for registration and ask for an annual charge from donors. Furthermore, there is low adoption of these products due to low reimbursements. For example, if the cost of the RBC unit is around USD150-USD165, the reimbursed amount comprises only USD75-USD80. Hence, such factors are expected to hinder the market during the forecast period.
The market forecast report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market forecasting and growth strategies.
Customer Landscape
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD Billion " for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.
The market is integral in addressing critical medical needs, including blood cancer, hemorrhagic diseases, and blood-borne infections. Innovations from leaders like Ortho Clinical Diagnostics have revolutionized the field with advanced hematology analyzers and state-of-the-art systems like the ORTHO VISION Analyzer and ORTHO optic reader system. Utilizing cutting-edge techniques such as the BioVue method and DG Reader Net, immunohematology devices play a crucial role in diagnosing blood malignancies and managing pregnancy-related reactions, hepatitis, and other conditions. Automation, including automatic analyzers and fully-automated devices, enhances diagnosis efficacy while reducing the risk of human error. Through initiatives like blood donation camps and awareness programs, both private entities and public entities collaborate to combat the spread of infection and raise awareness about blood associated diseases. With the support of the research fraternity and healthcare associations, regulations ensure safe practices in blood collection, processing, and testing across public healthcare settings and private healthcare settings.
Market Scope |
|
Report Coverage |
Details |
Page number |
169 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 7.35% |
Market growth 2024-2028 |
USD 1.06 billion |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
6.71 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 36% |
Key countries |
US, Germany, UK, Canada, and China |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
Becton Dickinson and Co., Biomed Global, Bio Rad Laboratories Inc., biosurfit SA, Cardinal Health Inc., Calibre Scientific Inc., Danaher Corp., DIAGAST SAS, Grifols SA, Hemo bioscience Inc., HUMAN Gesellschaft fur Biochemica und Diagnostica mbH, Institut de Biotechnologies Jacques Boy, MAK SYSTEM S.A., Merck KGaA, Mesa Laboratories Inc., Quotient Ltd., Siemens AG, Thermo Fisher Scientific Inc., Tulip Diagnostics Pvt. Ltd., and Werfenlife SA |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download Sample PDF at your Fingertips
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.